Ibandronate Increases Sclerostin Levels and Bone Strength in Male Patients with Idiopathic Osteoporosis

Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis

(2014) Davide Gatti et al.   BONE

Molecular evidence of osteoblast dysfunction in elderly men with osteoporotic hip fractures

(2014) Ursula Föger-Samwald et al.   EXPERIMENTAL GERONTOLOGY

Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density-The CONFORS Study

(2014) Christian Muschitz et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image

(2014) Barbara C Silva et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?

(2014) R. Sapir-Koren et al.   OSTEOPOROSIS INTERNATIONAL

Molecular Mechanisms of Osteoblast/Osteocyte Regulation by Connexin43

(2013) Joseph P. Stains et al.   CALCIFIED TISSUE INTERNATIONAL

Correlates of bone microarchitectural parameters and serum sclerostin levels in men: The STRAMBO study

(2013) Pawel Szulc et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab

(2013) Tony M Keaveny et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Intravenous Treatment With Ibandronate Normalizes Bone Matrix Mineralization and Reduces Cortical Porosity After Two Years in Male Osteoporosis: A Paired Biopsy Study

(2013) Barbara M Misof et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization

(2013) Kuniaki Ota et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Zoledronic Acid Acutely Increases Sclerostin Serum Levels in Women With Postmenopausal Osteoporosis

(2013) Antonino Catalano et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Trabecular Bone Score (TBS)—A Novel Method to Evaluate Bone Microarchitectural Texture in Patients With Primary Hyperparathyroidism

(2013) Barbara Campolina Silva et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial

(2013) Athanasios D. Anastasilakis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Sclerostin Levels Are Decreased in Adult Patients With Different Types of Osteogenesis Imperfecta

(2013) Roland Kocijan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Beyond gap junctions: Connexin43 and bone cell signaling

(2012) Lilian I. Plotkin et al.   BONE

A nonlinear QCT-based finite element model validation study for the human femur tested in two configurations in vitro

(2012) E. Dall'Ara et al.   BONE

Deletion of Cx43 from Osteocytes Results in Defective Bone Material Properties but Does Not Decrease Extrinsic Strength in Cortical Bone

(2012) Nicoletta Bivi et al.   CALCIFIED TISSUE INTERNATIONAL

The Pathogenesis, Treatment and Prevention of Osteoporosis in Men

(2012) Leif Mosekilde et al.   DRUGS

Bisphosphonates: effects on osteoblast

(2012) Nicola Maruotti et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia—a randomized placebo-controlled trial

(2012) R. D. Chapurlat et al.   OSTEOPOROSIS INTERNATIONAL

Fragility Fractures in Men with Idiopathic Osteoporosis Are Associated with Undermineralization of the Bone Matrix without Evidence of Increased Bone Turnover

(2011) Nadja Fratzl-Zelman et al.   CALCIFIED TISSUE INTERNATIONAL

Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury

(2011) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis

(2011) Janina M Patsch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults

(2011) Karin Amrein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of monthly ibandronate on hip structural geometry in men with low bone density

(2011) H. K. Genant et al.   OSTEOPOROSIS INTERNATIONAL

Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women

(2011) Y. E. Chung et al.   OSTEOPOROSIS INTERNATIONAL

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide

(2011) S. A. Polyzos et al.   OSTEOPOROSIS INTERNATIONAL

Efficacy and safety of monthly ibandronate in men with low bone density

(2010) Eric S. Orwoll et al.   BONE

Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability

(2010) Teresita Bellido et al.   BONE

A nonlinear finite element model validation study based on a novel experimental technique for inducing anterior wedge-shape fractures in human vertebral bodies in vitro

(2010) E. Dall'Ara et al.   JOURNAL OF BIOMECHANICS

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

(2010) Eric S Orwoll et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double-Blind, Placebo-Controlled Trial*

(2009) Astrid Fahrleitner-Pammer et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL